IL-12 Antagonism Induces T Helper 2 Responses, yet Exacerbates Cardiac Allograft Rejection: Evidence Against a Dominant Protective Role for T Helper 2 Cytokines in Alloimmunity

Joseph R. Piccotti, Sherri Y. Chan, Richard E. Goodman, Jeanne Magram, Ernst J. Eichwald, D. Keith Bishop

Research output: Contribution to journalArticle

129 Citations (Scopus)

Abstract

IL-12 promotes Th1 development and inhibits the generation of Th2 by inducing IFN-γ production. In several experimental models, Th2 are preferentially induced in the absence of IL-12. It was proposed that the preferential induction of Th2 by IL-12 antagonism would inhibit Th1-driven rejection responses, thereby promoting allograft acceptance. To test this possibility, mouse cardiac allograft recipients were treated with either anti-IL-12 Abs, or with the IL-12 receptor antagonist p40 homodimer. Unmodified rejection is characterized by a Th1-dominated response, with Th2 cytokines being absent or only weakly expressed within the allograft. Though both forms of IL-12 antagonism induced Th2 cytokine expression within the allograft, these treatments surprisingly exacerbated graft rejection relative to control animals. Interestingly, IL-12 antagonism did not inhibit IFN-γ gene expression or in vivo sensitization of IFN-γ-producing cells. Similar observations were made when IL-12 p40 knockout mice were used as allograft donors and recipients, verifying that IL-12 was not required for Th1 development. Further, IL-12 antagonism was associated with strong expression of p40 and weak expression of p35 within the graft. Neither p35 nor p40 mRNAs were detectable in control allografts. These data indicate that while IL-12 antagonism does induce Th2 cytokine expression within cardiac allografts, Th2 cytokines do not play a dominant protective role in the rejection process. Further, the Th2-inducing activity of IL-12 antagonism is not related to decreased IFN-γ production, but may reflect altered regulation of IL-12 itself.

Original languageEnglish (US)
Pages (from-to)1951-1957
Number of pages7
JournalJournal of Immunology
Volume157
Issue number5
StatePublished - Sep 1 1996

Fingerprint

Interleukin-12
Allografts
Cytokines
Interleukin-12 Receptors
Graft Rejection
Knockout Mice
Theoretical Models
Transplants
Gene Expression

ASJC Scopus subject areas

  • Immunology

Cite this

IL-12 Antagonism Induces T Helper 2 Responses, yet Exacerbates Cardiac Allograft Rejection : Evidence Against a Dominant Protective Role for T Helper 2 Cytokines in Alloimmunity. / Piccotti, Joseph R.; Chan, Sherri Y.; Goodman, Richard E.; Magram, Jeanne; Eichwald, Ernst J.; Bishop, D. Keith.

In: Journal of Immunology, Vol. 157, No. 5, 01.09.1996, p. 1951-1957.

Research output: Contribution to journalArticle

@article{b1b54cb6e23c4563bef684497f8bc8dd,
title = "IL-12 Antagonism Induces T Helper 2 Responses, yet Exacerbates Cardiac Allograft Rejection: Evidence Against a Dominant Protective Role for T Helper 2 Cytokines in Alloimmunity",
abstract = "IL-12 promotes Th1 development and inhibits the generation of Th2 by inducing IFN-γ production. In several experimental models, Th2 are preferentially induced in the absence of IL-12. It was proposed that the preferential induction of Th2 by IL-12 antagonism would inhibit Th1-driven rejection responses, thereby promoting allograft acceptance. To test this possibility, mouse cardiac allograft recipients were treated with either anti-IL-12 Abs, or with the IL-12 receptor antagonist p40 homodimer. Unmodified rejection is characterized by a Th1-dominated response, with Th2 cytokines being absent or only weakly expressed within the allograft. Though both forms of IL-12 antagonism induced Th2 cytokine expression within the allograft, these treatments surprisingly exacerbated graft rejection relative to control animals. Interestingly, IL-12 antagonism did not inhibit IFN-γ gene expression or in vivo sensitization of IFN-γ-producing cells. Similar observations were made when IL-12 p40 knockout mice were used as allograft donors and recipients, verifying that IL-12 was not required for Th1 development. Further, IL-12 antagonism was associated with strong expression of p40 and weak expression of p35 within the graft. Neither p35 nor p40 mRNAs were detectable in control allografts. These data indicate that while IL-12 antagonism does induce Th2 cytokine expression within cardiac allografts, Th2 cytokines do not play a dominant protective role in the rejection process. Further, the Th2-inducing activity of IL-12 antagonism is not related to decreased IFN-γ production, but may reflect altered regulation of IL-12 itself.",
author = "Piccotti, {Joseph R.} and Chan, {Sherri Y.} and Goodman, {Richard E.} and Jeanne Magram and Eichwald, {Ernst J.} and Bishop, {D. Keith}",
year = "1996",
month = "9",
day = "1",
language = "English (US)",
volume = "157",
pages = "1951--1957",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "5",

}

TY - JOUR

T1 - IL-12 Antagonism Induces T Helper 2 Responses, yet Exacerbates Cardiac Allograft Rejection

T2 - Evidence Against a Dominant Protective Role for T Helper 2 Cytokines in Alloimmunity

AU - Piccotti, Joseph R.

AU - Chan, Sherri Y.

AU - Goodman, Richard E.

AU - Magram, Jeanne

AU - Eichwald, Ernst J.

AU - Bishop, D. Keith

PY - 1996/9/1

Y1 - 1996/9/1

N2 - IL-12 promotes Th1 development and inhibits the generation of Th2 by inducing IFN-γ production. In several experimental models, Th2 are preferentially induced in the absence of IL-12. It was proposed that the preferential induction of Th2 by IL-12 antagonism would inhibit Th1-driven rejection responses, thereby promoting allograft acceptance. To test this possibility, mouse cardiac allograft recipients were treated with either anti-IL-12 Abs, or with the IL-12 receptor antagonist p40 homodimer. Unmodified rejection is characterized by a Th1-dominated response, with Th2 cytokines being absent or only weakly expressed within the allograft. Though both forms of IL-12 antagonism induced Th2 cytokine expression within the allograft, these treatments surprisingly exacerbated graft rejection relative to control animals. Interestingly, IL-12 antagonism did not inhibit IFN-γ gene expression or in vivo sensitization of IFN-γ-producing cells. Similar observations were made when IL-12 p40 knockout mice were used as allograft donors and recipients, verifying that IL-12 was not required for Th1 development. Further, IL-12 antagonism was associated with strong expression of p40 and weak expression of p35 within the graft. Neither p35 nor p40 mRNAs were detectable in control allografts. These data indicate that while IL-12 antagonism does induce Th2 cytokine expression within cardiac allografts, Th2 cytokines do not play a dominant protective role in the rejection process. Further, the Th2-inducing activity of IL-12 antagonism is not related to decreased IFN-γ production, but may reflect altered regulation of IL-12 itself.

AB - IL-12 promotes Th1 development and inhibits the generation of Th2 by inducing IFN-γ production. In several experimental models, Th2 are preferentially induced in the absence of IL-12. It was proposed that the preferential induction of Th2 by IL-12 antagonism would inhibit Th1-driven rejection responses, thereby promoting allograft acceptance. To test this possibility, mouse cardiac allograft recipients were treated with either anti-IL-12 Abs, or with the IL-12 receptor antagonist p40 homodimer. Unmodified rejection is characterized by a Th1-dominated response, with Th2 cytokines being absent or only weakly expressed within the allograft. Though both forms of IL-12 antagonism induced Th2 cytokine expression within the allograft, these treatments surprisingly exacerbated graft rejection relative to control animals. Interestingly, IL-12 antagonism did not inhibit IFN-γ gene expression or in vivo sensitization of IFN-γ-producing cells. Similar observations were made when IL-12 p40 knockout mice were used as allograft donors and recipients, verifying that IL-12 was not required for Th1 development. Further, IL-12 antagonism was associated with strong expression of p40 and weak expression of p35 within the graft. Neither p35 nor p40 mRNAs were detectable in control allografts. These data indicate that while IL-12 antagonism does induce Th2 cytokine expression within cardiac allografts, Th2 cytokines do not play a dominant protective role in the rejection process. Further, the Th2-inducing activity of IL-12 antagonism is not related to decreased IFN-γ production, but may reflect altered regulation of IL-12 itself.

UR - http://www.scopus.com/inward/record.url?scp=0030240073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030240073&partnerID=8YFLogxK

M3 - Article

C2 - 8757314

AN - SCOPUS:0030240073

VL - 157

SP - 1951

EP - 1957

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 5

ER -